Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity

por Koleini, Navid, Kardami, Elissavet
Publicado 2017

Together and apart: inhibition of DNA synthesis by connexin-43 and its relationship to transforming growth factor β

por Jeyaraman, Maya M., Fandrich, Robert R., Kardami, Elissavet
Publicado 2013

Low and High Molecular Weight FGF-2 Have Differential Effects on Astrocyte Proliferation, but Are Both Protective Against Aβ-Induced Cytotoxicity

por Chen, Xi, Li, Zhaojin, Cheng, Yong, Kardami, Elissavet, Loh, Y. Peng
Publicado 2020

Antidepressant-Like Effects of Low- and High-Molecular Weight FGF-2 on Chronic Unpredictable Mild Stress Mice

por Wang, Lin, Li, Xi-Xi, Chen, Xi, Qin, Xiao-Yan, Kardami, Elissavet, Cheng, Yong
Publicado 2018

Non-mitogenic FGF2 protects cardiomyocytes from acute doxorubicin-induced toxicity independently of the protein kinase CK2/heme oxygenase-1 pathway

por Koleini, Navid, Nickel, Barbara E., Edel, Andrea L., Fandrich, Robert R., Ravandi, Amir, Kardami, Elissavet
Publicado 2018

A Cardiac Mitochondrial FGFR1 Mediates the Antithetical Effects of FGF2 Isoforms on Permeability Transition

por Srisakuldee, Wattamon, Nickel, Barbara E., Fandrich, Robert R., Zhang, Feixong, Pasumarthi, Kishore B. S., Kardami, Elissavet
Publicado 2021

Fibroblast growth factor-2-mediated protection of cardiomyocytes from the toxic effects of doxorubicin requires the mTOR/Nrf-2/HO-1 pathway

por Koleini, Navid, Nickel, Barbara E., Wang, Jie, Roveimiab, Zeinab, Fandrich, Robert R., Kirshenbaum, Lorrie A., Cattini, Peter A., Kardami, Elissavet
Publicado 2017

High Molecular Weight Fibroblast Growth Factor-2 in the Human Heart Is a Potential Target for Prevention of Cardiac Remodeling

por Santiago, Jon-Jon, McNaughton, Leslie J., Koleini, Navid, Ma, Xin, Bestvater, Brian, Nickel, Barbara E., Fandrich, Robert R., Wigle, Jeffrey T., Freed, Darren H., Arora, Rakesh C., Kardami, Elissavet
Publicado 2014

Calreticulin Induces Dilated Cardiomyopathy

por Lee, Dukgyu, Oka, Tatsujiro, Hunter, Beth, Robinson, Alison, Papp, Sylvia, Nakamura, Kimitoshi, Srisakuldee, Wattamon, Nickel, Barbara E., Light, Peter E., Dyck, Jason R. B., Lopaschuk, Gary D., Kardami, Elissavet, Opas, Michal, Michalak, Marek
Publicado 2013

Correction: Calreticulin Induces Dilated Cardiomyopathy

por Lee, Dukgyu, Oka, Tatsujiro, Hunter, Beth, Robinson, Alison, Papp, Sylvia, Nakamura, Kimitoshi, Srisakuldee, Wattamon, Nickel, Barbara E., Light, Peter E., Dyck, Jason R. B., Lopaschuk, Gary D., Kardami, Elissavet, Opas, Michal, Michalak, Marek
Publicado 2013

SKI activates the Hippo pathway via LIMD1 to inhibit cardiac fibroblast activation

por Landry, Natalie M., Rattan, Sunil G., Filomeno, Krista L., Meier, Thomas W., Meier, Simon C., Foran, Sarah J., Meier, Claire F., Koleini, Navid, Fandrich, Robert R., Kardami, Elissavet, Duhamel, Todd A., Dixon, Ian M. C.
Publicado 2021